Artificial lung

End-stage lung disease, namely chronic obstructive pulmonary diseases (COPD), represent the fourth leading cause of death worldwide (1). The increasing rates of tobacco smoking and exposure to air pollutants will further raise the number of COPD patients thus creating an urgent need for new therapeutic strategies